GLAD 10-K Fiscal 2026: NAV $20.77, 5 Non-Accruals, $0.15 Monthly
Some links pay us a referral fee; each one says so. Disclosure
Filing alert · free
An email when Gladstone Capital (GLAD) files with the SEC
An email the day Gladstone Capital (GLAD) files something new, with the link to the document on the SEC site.
Quick answer
Gladstone Capital Corporation (Nasdaq: GLAD, SEC CIK 1143513) filed its Form 10-K for the year ended September 30, 2026 on November 17, 2026 (accession 0001143513-26-000014), with an 8-K the same day carrying the earnings release (accession 0001193125-26-465633). NAV per share was $20.77 at September 30, 2026, from $21.50 at June 30, 2026 and $21.34 at September 30, 2025 (down 2.7% in the year, our arithmetic). Net investment income (NII) was $0.49 a share for the quarter and $2.00 for the year, against $1.98 of distributions declared for the year, of which $0.18 was a September 2026 supplemental. The board declared $0.15 a month for October, November and December 2026, the same $0.45 a quarter as before. Five loans stayed on non-accrual: $52.9 million at cost (6.0% of debt investments) and $23.8 million at fair value (2.8%), up from three loans at $28.8 million and $13.0 million a year earlier. The stock's low in the quarter to September 30, 2026 was $18.53 and its range from October 1 to November 16, 2026 was $18.16 to $20.00. As of November 18, 2026.
Key takeaways
- The monthly dividend did not change; the quarter's NAV fall came from losses and the supplemental. The board declared $0.15 for each of October, November and December 2026 (10-K, Liquidity and Capital Resources). In the quarter to September 30, 2026 NAV fell $0.73 to $20.77: $0.55 of net realized and unrealized losses and the $0.18 supplemental paid on September 16, 2026. Fiscal 2026 distributions were $1.98 a share ($1.80 regular plus $0.18), against $2.48 in fiscal 2025.
- The regular dividend is covered 104.5%, the total payout is not. After $2.6 million of preferred dividends, the company says NII covered 104.5% of the $40.7 million of regular distributions in fiscal 2026 and about 100% in the fourth quarter. Our arithmetic on the same figures: NII after preferred of $42.5 million is 95.0% of the $44.7 million of common distributions paid once the supplemental is included.
- Non-accruals are five loans in the same five companies for the second straight quarter, but they are worth less. Cost rose from $50.5 million at June 30, 2026 to $52.9 million; fair value fell from $30.6 million to $23.8 million, 45.1% of cost (our arithmetic). Eegee Acquisition Corp. is $17.4 million of cost carried at $8.2 million, and B+T Group Acquisition is $7.8 million carried at zero (our sums of the schedule of investments).
- Leverage went up as the portfolio grew 11.3%. Total principal debt was $447.5 million, debt to equity including the preferred as debt 1.08x against 0.89x a year earlier, and the revolver was $188.0 million drawn of $385.0 million. Interest expense rose to $25.0 million from $20.0 million (our rounding of $24,969 thousand and $19,986 thousand). The next note maturity is $50.0 million of 3.75% Notes on May 1, 2027.
- A below-NAV share sale is on the ballot. A preliminary proxy statement filed on November 9, 2026 asks holders to authorize selling up to 25% of the common shares in a sale at a price below NAV, for 12 months, with “no limit on the discount to NAV at which shares could be sold”. The meeting is February 4, 2027; the record date is December 4, 2026.
- No GLAD note or preferred share trades. The 10-K says the 6.25% Series A preferred, the 2027 notes, the 2029 notes and the 2030 convertible notes “are not listed or traded on any exchange”. The only listed GLAD note, the 7.75% Notes due 2028 (ticker GLADZ), was redeemed on October 15, 2025.
CSV · 208 rows
Gladstone Capital (GLAD) 10-K for fiscal 2026: NAV bridge, earnings, distributions, non-accruals by company, fees and credits, debt, preferred stock and price
208 rows from GLAD's 10-K, the November 17, 2026 8-K and the November 9, 2026 preliminary proxy: NAV and the per-share bridge, earnings, distributions paid and declared, non-accruals by company, Adviser fees and credits, debt, Series A preferred and price. Form and accession number on every row.
What is new since our June 2026 page
Our earlier GLAD page read the June 30, 2026 10-Q and stopped at NAV of $21.50 with the 10-K still to come. This page is the year-end reading, and four things in it were not knowable in October.
- The October declaration is now in a filing. The earlier page had it only from news reports. The 8-K and the 10-K both give three monthly $0.15 distributions with record dates of October 23, November 19 and December 21, 2026.
- The non-accrual total at June 30, 2026 was higher than the 10-Q's text said. The earnings release gives the same five companies at $50.5 million of cost (5.8%) and $30.6 million of fair value (3.6%) for June 30, 2026, which matches the sum our earlier page made of the flagged lines in the June schedule, not the $46.0 million and $26.7 million of the 10-Q's text that it also quoted.
- A below-NAV sale proposal appeared in the November 9, 2026 preliminary proxy (see below).
- The Adviser's incentive-fee credit came back for one quarter. The earlier page counted none in fiscal 2026; the 10-K shows $0.5 million of credit for the year, and the release puts it in the fourth quarter.
Fiscal 2026 against fiscal 2025
| Item | Fiscal 2026 (year to September 30, 2026) | Fiscal 2025 |
|---|---|---|
| Total investment income | $99.6 million | $89.1 million |
| Total expenses, net of credits | $54.4 million | $43.9 million |
| Net investment income | $45.1 million ($2.00 a share) | $45.2 million ($2.02 a share) |
| Net realized gain on investments | $2.8 million | $55.4 million |
| Net unrealized depreciation | ($11.5 million) | ($42.7 million) |
| Preferred stock dividends | $2.6 million | $0.9 million |
| Distributions declared per common share | $1.98 ($1.80 regular, $0.18 supplemental) | $2.48 ($1.98 regular, $0.50 supplemental) |
| NAV per share, end of year | $20.77 | $21.34 |
| Market value per share, end of year | $19.23 | $21.87 |
| Total return on market value (company figure) | (2.65)% | (0.17)% |
| Weighted average yield on interest-bearing investments | 11.9% | 12.7% |
Investment income rose 11.7% because the interest-bearing portfolio grew 17.9% on average ($803.0 million against $681.1 million) while the yield fell 0.8 point; net expenses rose 24.0%, so NII was flat. Of the $10.5 million increase in net expenses, the 10-K assigns $5.0 million to interest expense, $2.9 million to the net base management fee and $1.9 million to the net incentive fee. PIK interest, which is added to the loan rather than paid in cash, was $6.9 million, 6.9% of investment income (our arithmetic), against $5.0 million, 5.6% a year earlier. Dividend income rose from $0.5 million to $2.2 million.
The per-share bridge in the 10-K's financial highlights shows where NAV went:
| Per common share | Fiscal 2026 | Fiscal 2025 |
|---|---|---|
| NAV at beginning of year | $21.34 | $21.18 |
| Net investment income | $2.00 | $2.02 |
| Net realized and unrealized gain (loss) on investments | ($0.39) | $0.57 |
| Net realized and unrealized loss on other | ($0.08) | $0.01 |
| Preferred stock dividends | ($0.11) | ($0.04) |
| Distributions from net investment income | ($1.77) | ($1.98) |
| Distributions from realized gains | ($0.21) | ($0.50) |
| Effect of equity offering and other | ($0.01) | $0.08 |
| NAV at end of year | $20.77 | $21.34 |
Fiscal 2025 was held up by a $59.3 million gain on one sale (the 10-K names Antenna Research Associates) that paid for $0.50 of supplementals. Fiscal 2026 had no such gain: net realized gains were $2.8 million and unrealized depreciation $11.5 million, which together are the $0.39 loss per share on investments. The release says fourth-quarter unrealized depreciation “was concentrated in two existing non-earning investments and several previously appreciated equity positions”; the 10-K's year table names Eegee Acquisition Corp. (a $14.0 million unrealized loss), Lonestar EMS (a $5.6 million loss) and B+T Group Acquisition (a $3.3 million loss) among the largest, offset by gains at Dutch Gold Honey ($7.4 million) and Canopy Safety Brands ($2.9 million). Unrealized depreciation on control investments alone was $20.2 million.
The dividend: $0.15 a month, and what pays for it
| Quarter | NAV at quarter-end | High and low price in the quarter | Common distributions declared |
|---|---|---|---|
| Quarter ended December 31, 2025 | $21.13 | $21.96 and $18.76 | $0.450 |
| Quarter ended March 31, 2026 | $21.36 | $21.35 and $16.54 | $0.450 |
| Quarter ended June 30, 2026 | $21.50 | $20.20 and $17.02 | $0.450 |
| Quarter ended September 30, 2026 | $20.77 | $20.40 and $18.53 | $0.630 ($0.45 regular plus $0.18 supplemental) |
| Quarter ending December 31, 2026 (through November 16, 2026) | not yet determined | $20.00 and $18.16 | $0.450 declared |
The distribution has been $0.15 a month since the board cut it from $0.165 for October 2025. The 10-K's Item 5 shows the stock below NAV at its low in each of the last four quarters and above it at its high only in the quarter to December 31, 2025 (3.9%); at the end of fiscal 2026 the market value of $19.23 was 92.6% of NAV (our arithmetic). The $1.80 annual rate is 8.7% of NAV and 9.4% of the $19.23 market value (our arithmetic).
Coverage depends on which line you take.
| Measure | Result |
|---|---|
| NII per share, fiscal 2026 (company) | $2.00 |
| Preferred stock dividends per common share (10-K financial highlights) | $0.11 |
| NII after preferred over regular distributions, fiscal 2026 (company) | 104.5% |
| NII after preferred over regular distributions, quarter to September 30, 2026 (company) | about 100% |
| NII after preferred ($42.5 million) over all common distributions paid ($44.7 million), fiscal 2026 (our arithmetic) | 95.0% |
| Fiscal 2025 distributions of $2.48 over NII of $2.02 (our arithmetic) | 123% |
The preferred dividends are the line a quote page skips: Gladstone Capital reports NII before them and deducts them lower down. They rose from $0.9 million to $2.6 million as the Series A preferred grew (below). The 10-K also says that in fiscal 2026 the Adviser credited $0.5 million against the income incentive fee “to the extent net investment income did not cover 100.0% of distributions to common stockholders”, against $2.3 million in fiscal 2025. Without all of the Adviser's credits, the 10-K's financial highlights put NII at 6.07% of average net assets instead of the reported 9.36% (5.93% against 9.44% a year earlier); that comparison includes the loan servicing credit, which is a prepayment of the base fee and not a waiver, so it overstates the gift.
The tax side is in the 10-K as well. The company elected under Section 855(a) of the Internal Revenue Code to treat $5.4 million of taxable income and $0.1 million of net capital gains as paid in fiscal 2026 out of the first distributions paid in fiscal 2027. The split between ordinary income, capital gain and return of capital for calendar 2026 will be on Form 1099-DIV, not in this filing.
The five non-accruals, by company
A loan goes on non-accrual when the company stops recognizing its interest income. The 10-K's schedule of investments flags the lines; adding the flagged debt lines by company gives these figures, which add up to the $52.9 million of cost and $23.8 million of fair value the 10-K reports (our sums of the schedule rows).
| Company (flagged debt lines) | Cost, September 30, 2026 ($ thousand) | Fair value ($ thousand) | Fair value as % of cost (our arithmetic) |
|---|---|---|---|
| Eegee Acquisition Corp. (line of credit) | 17,350 | 8,236 | 47.5% |
| WB Xcel Holdings, LLC (line of credit and term debt) | 14,925 | 10,150 | 68.0% |
| B+T Group Acquisition, Inc. (two lines of credit and term debt) | 7,770 | 0 | 0.0% |
| Lonestar EMS, LLC (line of credit and term debt) | 6,700 | 5,354 | 79.9% |
| Edge Adhesives Holdings, Inc. (term debt) | 6,140 | 104 | 1.7% |
| Total | 52,885 | 23,844 | 45.1% |
| Date | Non-accrual cost | % of debt at cost | Non-accrual fair value | % of debt at fair value | Companies |
|---|---|---|---|---|---|
| September 30, 2025 | $28.8 million | 3.6% | $13.0 million | 1.7% | B+T Group, Edge Adhesives, WB Xcel |
| June 30, 2026 (release, same five) | $50.5 million | 5.8% | $30.6 million | 3.6% | adds Eegee and Lonestar EMS |
| September 30, 2026 | $52.9 million | 6.0% | $23.8 million | 2.8% | the same five |
The release states that “no investments were added to or removed from non-accrual status during the quarter”, so the $6.8 million fall in fair value since June 30, 2026 (our arithmetic on $30.6 million and $23.8 million) is markdowns and the $2.4 million of added cost sits in the same five companies. Edge Adhesives and B+T Group have carried their loans on this list since at least September 30, 2025, and the 10-K shows Edge's $6.1 million term loan at $0.1 million. The two largest names by cost, Eegee and WB Xcel, are 61.0% of the cost on non-accrual (our arithmetic). The schedule shows both WB Xcel lines with a November 2026 due date. The 10-K also holds preferred equity in Edge Adhesives and B+T Group; those equity positions are not in the non-accrual percentages, which are debt only.
Overall the portfolio was valued at 97.1% of cost at September 30, 2026, against 98.0% a year earlier, with fair value $29.0 million under a cost of $984.8 million.
Investing and repayments
| Fiscal year ended September 30 | Fiscal 2026 | Fiscal 2025 |
|---|---|---|
| Invested in new portfolio companies | $171.4 million (11 companies) | $310.7 million |
| Invested in existing portfolio companies | $137.4 million | $86.1 million |
| Total invested | $308.7 million | $396.8 million |
| Repayments and net proceeds | $210.0 million (release) | $352.6 million |
| Portfolio at fair value, end of year | $955.8 million (59 companies) | $859.1 million (55 companies) |
New money exceeded repayments by $98.7 million (our arithmetic), which is the main reason leverage rose. The portfolio at fair value was 72.9% secured first lien debt, 15.8% second lien, 4.7% preferred equity and 6.5% common equity at September 30, 2026. In the fourth quarter the company invested $83.9 million, $32.8 million of it in two new companies, and received $70.7 million of repayments. Contractual principal due by fiscal year, assuming no early repayment, is $81.9 million in fiscal 2027 and $142.8 million in fiscal 2028. A subsequent event: in November 2026 the company invested a further $6.9 million in Quality Environmental Midco, Inc., an existing portfolio company.
Debt, notes and the preferred stock
| Instrument | Amount at September 30, 2026 | Rate | Maturity or key date | Listed? |
|---|---|---|---|---|
| KeyBank revolving credit facility | $188.0 million drawn of a $385.0 million commitment | margin of 2.60% in the revolving period | Revolving period ends October 31, 2027; final maturity October 31, 2029 | No |
| 3.75% Notes due 2027 | $50.0 million | 3.75% | May 1, 2027 | No |
| 7.00% Notes due 2029 | $60.0 million | 7.00%, issued June 2026 | December 15, 2029 | No |
| 5.875% Convertible Notes due 2030 | $149.5 million | 5.875% | October 1, 2030; conversion price $25.66 | No |
| 6.25% Series A Cumulative Redeemable Preferred Stock | 2,283,854 shares, $57.1 million at liquidation preference | $0.130208 a month per $25 share | Offering ends December 31, 2026 unless extended or sold out | No |
The 10-K says the preferred stock and all three outstanding note issues are “not listed or traded on any exchange or automated quotation system”, so there is no GLAD note or preferred ticker to look up today. In October 2025 the company redeemed the 7.75% Notes due 2028 ($57.0 million, which traded as GLADZ) and the 5.125% Notes due 2026 ($150.0 million), both before maturity.
Total principal debt was $447.5 million: $188.0 million on the revolver and $259.5 million of notes. The company reports asset coverage of 212.7% against the 150% minimum under the Investment Company Act of 1940, debt to equity of 1.08x with the preferred counted as debt (1.00x at June 30, 2026 and 0.89x a year earlier) and 0.95x on principal debt alone, and 42.0% of principal debt at floating rates. The revolver had about $177.7 million available under its borrowing base, so the $50.0 million of 3.75% Notes due May 1, 2027 is smaller than the unused line, subject to the covenants (our reading, not a statement by the company). The revolver's weighted average balance was $170.1 million against $40.2 million in fiscal 2025.
If the convertible notes converted at the conversion rate of 38.96 shares per $1,000, they would turn into about 5.8 million shares, 25.8% of the 22.6 million shares outstanding (our arithmetic); the conversion price of $25.66 is 33.4% above the $19.23 market value at September 30, 2026. The company may settle in cash, shares or both.
The Series A preferred is the fastest-growing piece. In fiscal 2026 the company sold 1,467,066 shares for $36.7 million gross and $32.8 million net, repurchased 48,664 shares for $1.2 million, and paid Gladstone Securities, an affiliate of the Adviser, $3.7 million of selling commissions and dealer manager fees, 10.1% of gross proceeds (our arithmetic). Net proceeds were $22.34 per $25 share sold (our arithmetic). The remaining capacity is 3,716,146 shares. At $57.1 million the preferred costs $3.6 million a year at 6.25% (our arithmetic), paid ahead of common.
Fees, and the Adviser's credits
| $ thousand | Fiscal 2026 | Fiscal 2025 |
|---|---|---|
| Base management fee, gross | 16,264 | 13,910 |
| Portfolio company fee credit | (5,094) | (5,593) |
| Net base management fee | 11,170 | 8,280 |
| Income incentive fee, gross | 10,502 | 10,486 |
| Incentive fee credit | (480) | (2,344) |
| Net incentive fee | 10,022 | 8,142 |
| Total credits to fees from Adviser, other than the loan servicing credit | (5,574) | (7,974) |
| Total expenses, net of credits | 54,443 | 43,915 |
The 10-K calls the credits “non-contractual, unconditional and irrevocable”, which means the Adviser has given them up but is not obliged to repeat them. They fell from $8.0 million to $5.6 million, and the net base and incentive fees together rose 29.0% (our arithmetic on $21.2 million against $16.4 million). The company also reports off-balance-sheet success fee receivables on accruing loans of $10.4 million, about $0.46 a share, against $6.0 million a year earlier; these are owed generally on a change of control of the portfolio company.
A proposal to sell shares below NAV
On November 9, 2026 the company filed a preliminary proxy statement (accession 0001193125-26-453565) for its annual meeting on Thursday, February 4, 2027 at 11:00 a.m. Eastern Time, held virtually. Proposal 1 elects two directors. Proposal 2 would authorize the company, with the board's later approval, to sell common stock at a price below NAV during the following 12 months, with each sale limited to 25% of the common shares outstanding just before it. The proxy states that if approved there would be “no limit on the discount to NAV at which shares could be sold”. The record date is December 4, 2026. It is a preliminary filing and the share counts are blank; a definitive proxy had not been filed as of November 18, 2026.
The company's own dilution table in the proxy shows what such a sale does to an existing holder. In its example a 25% sale at a 25% discount, from 1,000,000 shares at $10.00 NAV, leaves NAV at $9.50 (a 5.00% decrease) for a holder who kept the same shares. The company has sold no common stock under its at-the-market program in fiscal 2026 and says it has $129.4 million of capacity left. With the stock under NAV at the end of the year, it cannot sell shares at the market price without this kind of approval or a rights offering, which the 10-K states in its discussion of equity issuance.
What a holder can do with this
This is a checklist built from the documents, not a recommendation.
- Plan on $0.15 a month and read the supplemental as extra. The $0.18 of September 2026 was declared on August 31, 2026; the 8-K and 10-K give no commitment beyond December 2026.
- Compare earnings with the whole payout. Regular distributions were covered at 104.5% after preferred dividends, but all distributions paid were 95.0% covered (our arithmetic).
- Read the five non-accruals by name. Cost on the list is 6.0% of debt, fair value 2.8%; Eegee is the largest line and B+T Group is carried at zero.
- Look at the preferred and the credits. Preferred dividends rose to $2.6 million and the Adviser's credits fell to $5.6 million.
- Dates: record date November 19, 2026 and payment November 30, 2026 for the next common distribution; December 4, 2026 is the proxy record date; the preferred offering ends December 31, 2026; the annual meeting is February 4, 2027.
- If you also hold other business development companies, our census of BDC non-accruals, the list of listed BDCs and the sister company's page on Gladstone Investment put these figures beside others.
- For tax, use your Form 1099-DIV; we do not give tax advice.
This is analysis of public documents, not investment, legal or tax advice. We do not give price targets or say whether to buy, sell or hold.
FAQ
All figures are from Gladstone Capital Corporation's filings on SEC EDGAR (CIK 1143513), read on November 18, 2026: the Form 10-K for the year ended September 30, 2026 (accession 0001143513-26-000014, document glad-20260930.htm, filed November 17, 2026), including Item 5, the management's discussion, the statements of assets and liabilities and of operations, the schedule of investments at September 30, 2026 and Notes 4, 5, 6, 9 and 12; the Form 8-K of November 17, 2026 (accession 0001193125-26-465633) with its Exhibit 99.1 earnings release; and the preliminary proxy statement of November 9, 2026 (accession 0001193125-26-453565). Per-company non-accrual figures are our sums of the flagged lines in the schedule of investments. This is analysis of public documents, not investment, legal or tax advice.